Consultations

This consultation is for interim decisions made in relation to applications to amend the Poisons Standard, following advice sought at the 3-4 November 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

This consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-25 June 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS).

This consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-25 June 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

Submissions published and summarised as part of a consultation on medical devices that are substances for introduction into the body.

View the outcomes of public consultation on building a more robust medicine supply

The TGA is seeking feedback on the updated 'Listed medicines evidence guidelines - How to demonstrate efficacy of listed medicines'. Closing date: 1 April 2022

Outcomes of the consultation and submissions received have now been published

The TGA is seeking feedback on a proposal to remake some of the legislative instruments relating to human cell and tissue (HCT) products (including blood and blood components), which sunset in October 2021. Closing date: 11 July 2021

Outcomes of the consultation and submissions received have now been published

Outcomes of the consultation and submissions received have now been published

The TGA is seeking feedback on proposed advisory statements for OTC medicines containing methyl salicylate for inclusion in RASML. Closing date: 18 May 2021

Outcomes of the consultation and submissions received have now been published

The outcomes of the public consultation into proposed improvements to the Therapeutic Goods Advertising Code have been published.

The closing date has been extended and now closes on 14 July

A further update by the TGA on the proposed reforms to medicinal cannabis, labelling and packaging requirements.

Proposed amendments to the Poisons Standard, including substances in hand sanitisers. Closing date: 27 May 2021

Proposed amendments to the Poisons Standard. Closing date: 4 June 2021

A submission summary on the Australian Regulations definition of CCS consultation is available on our consultation hub

The closing date for this consultation has been extended until 27 May 2021

Proposed amendments to the Poisons Standard. Closing date: 27 May 2021

Proposed amendments to the Poisons Standard. Closing date: 27 May 2021

The Australian Government is undertaking a significant program to reform the regulation of therapeutic goods in Australia. As part of the Australian Government Department of Health, the Therapeutic Goods Administration (TGA) regulates therapeutic goods, and is responsible for implementing the Government’s reforms. The TGA has issued this survey as part of the Government’s reform program.

The IMDRF working group is seeking comments from interested parties on the proposed guidance document. Closing date: 19 April 2021

The closing date has been extended until 30 March 2021.

TGA is seeking comments on whether the Australian medical device regulatory framework should be aligned to the EU framework for medical devices containing nanomaterials. Closing date: 9 April 2021